Overview

A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin

Status:
RECRUITING

Trial end date:
2026-07-18

Target enrollment:

Participant gender:

Summary

The aim of this trial is to evaluate the efficacy and safety of HRS-7535 compared with dapagliflozin in subjects with type 2 diabetes mellitus with inadequate glycemic control using metformin.

Phase:

PHASE3

Details

Lead Sponsor:

Shandong Suncadia Medicine Co., Ltd.

Treatments:

dapagliflozin